Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Other Non-Current Assets: 2018-2024

Historic Other Non-Current Assets for Bicycle Therapeutics (BCYC) over the last 7 years, with Dec 2024 value amounting to $11.1 million.

  • Bicycle Therapeutics' Other Non-Current Assets rose 37.95% to $13.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.7 million, marking a year-over-year increase of 37.95%. This contributed to the annual value of $11.1 million for FY2024, which is 91.19% up from last year.
  • Per Bicycle Therapeutics' latest filing, its Other Non-Current Assets stood at $11.1 million for FY2024, which was up 91.19% from $5.8 million recorded in FY2023.
  • In the past 5 years, Bicycle Therapeutics' Other Non-Current Assets registered a high of $11.1 million during FY2024, and its lowest value of $1.8 million during FY2020.
  • For the 3-year period, Bicycle Therapeutics' Other Non-Current Assets averaged around $8.4 million, with its median value being $8.5 million (2022).
  • As far as peak fluctuations go, Bicycle Therapeutics' Other Non-Current Assets surged by 145.30% in 2022, and later tumbled by 31.52% in 2023.
  • Bicycle Therapeutics' Other Non-Current Assets (Yearly) stood at $1.8 million in 2020, then skyrocketed by 89.24% to $3.4 million in 2021, then surged by 145.30% to $8.5 million in 2022, then crashed by 31.52% to $5.8 million in 2023, then skyrocketed by 91.19% to $11.1 million in 2024.